Idorsia ‘Progressing Very Well’ with Prep for Anticipated Launch of Insomnia Drug Candidate

Allschwil, Switzerland-based Idorsia Ltd recently announced its financial results for the first half of 2021, at which time its drug daridorexant for the treatment of insomnia under review with United States FDA, EMA, and Swissmedic.

Leave a Reply